We had several financings that didnt make the 12/1 edition of Vital Signs. Biolexis Therapeutics – a company using AI for metabolic drug discovery, raised a $10M Series A. (American
When a startup or an investment is successful, it’s more likely that we attribute the outcome to a great idea and solid execution. While these two attributes are critical, they
We had several financings that didnt make the 11/14 edition of Vital Signs. VectorY Therapeutics – a biotech company developing antibody therapies to treat neurodegenerative diseases, raised a $138M Series
Listings that didn’t get included in the 11/7/23 edition of Vital Signs are here. If you are NOT receiving Vital Signs via email, send us a note and we’ll make
The slow medtech IPO (Initial Public Offering) market in 2023 is having a significant impact on venture capital investments in the medical technology (medtech) sector. For purposes of this post,
Listings that didn’t get included in the 9/29/23 edition of Vital Signs are here. If you are NOT receiving Vital Signs via email, send us a note and we’ll make
Medtech financings continue at a rapid pace led by therapeutics, AI and robotics. Below are just a few of the fundings we couldnt fit into a Vital Signs newsletter. CMR
Mark Sanborn is a leading author and speaker with deep expertise on the topics of leadership and teams. His most recent post shares 10 mistakes leaders make in their thinking.
While animal health is not at the top of the news cycle in healthcare, it continues to be a space that attracts considerable PE attention and money. On the one
Lots of AngelMD members are involved in medical missions work at one time or another. Some founded organizations and others attend missions trips when able. Medical Missions are an incredible
AngelMD is a large and growing healthcare innovation community connecting clinicians, startups, investors, Industry and other stakeholders.
AngelMD is a large and growing healthcare innovation community centered around clinician & startups with tools & education for both.